Back to Search
AMBER BEITELSHEES, PHARM.D., M.P.H.
PHARM.D., M.P.H.
Pharmacist
NPI: 1447449657Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PS35818(FL)
Research & Publications (20)
Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.
PMID 18351457·Heart Fail Rev·2010
6-review
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).
PMID 17700361·Pharmacogenet Genomics·2007
3-trial
Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
PMID 16945046·Pharmacotherapy·2006
3-trial
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.
PMID 19571804·Clin Pharmacol Ther·2009
2-rct
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
PMID 19249413·Am Heart J·2009
2-rct
Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetes.
PMID 19092169·Diabetes Care·2009
8-other
Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins.
PMID 18769620·PLoS One·2008
8-other
Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).
PMID 18657677·Am Heart J·2008
4-observational
Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
PMID 17496726·Pharmacogenet Genomics·2007
8-other
Single nucleotide polymorphism discovery and haplotype analysis of Ca2+-dependent K+ channel beta-1 subunit.
PMID 17496725·Pharmacogenet Genomics·2007
8-other
NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes.
PMID 17327342·Diabetes Care·2007
8-other
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease.
PMID 17254561·Clin Chim Acta·2007
8-other
Common laboratory methods in pharmacogenomics studies.
PMID 17057047·Am J Health Syst Pharm·2006
8-other
Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety.
PMID 16876261·Trends Pharmacol Sci·2006
6-review
Clopidogrel pharmacogenetics: promising steps towards patient care?
PMID 16857956·Arterioscler Thromb Vasc Biol·2006
6-review
Re: Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis. Pharmacogenet Genom 2006; 16:139-147.
PMID 16847430·Pharmacogenet Genomics·2006
8-other
Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugs.
PMID 16595569·Ann Pharmacother·2006
8-other
CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).
PMID 16567110·Cytokine·2006
8-other
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
PMID 15592325·Clin Pharmacol Ther·2004
8-other
Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.
PMID 15483659·Pharmacogenomics J·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1601 SW ARCHER RD
GAINESVILLE, FL 32608 - Phone
- (352) 376-1611
Quick Facts
- NPI
- 1447449657
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile